Categories
Pages
-

SmartMedCN

Alibaba, Yunfeng to Buy Control of Citic 21CN for $171 Million

January 29th, 2014 | by

Alibaba Group Holding Ltd., the owner of China’s biggest e-commerce business, and Yunfeng Capital said they will buy control of Citic 21CN Co. (241) for HK$1.33 billion ($171 million) to enter the drug-data industry.

“The transaction is the foundation for a strategic partnership aiming at jointly driving development of a pharmaceutical-product information platform,” Alibaba said in an e-mailed statement yesterday. The platform will use Citic 21CN’s drug data and Alibaba’s e-commerce, cloud computing and “big data” capabilities, it said. (Source: Bloomberg)

 

阿里巴巴投1.7亿欲进军医疗健康领域

来源:中关村在线 作者:医药卫生网

随着健康领域的逐渐火热,越来越多的IT巨头准备插手智能健康领域。近日消息,阿里巴巴集团宣布,联手云锋基金,对中信集团旗下中信二十一世纪有限公司(下称“中信21CN”)进行总额1.7亿美元的战略投资。
中信21CN公告显示,阿里巴巴集团将联合云锋基金通过认购中信21CN增发新股的方式,对其完成1.7亿美元战略投资。交易完成后,阿里巴巴和云锋基金将持有中信21CN54.3%的股份,其中阿里巴巴集团持股38.1%,云锋基金持股16.2%。
投资完成后,中信21CN与阿里云计算平台将进一步完成后台数据的打通和对接,联手推进国内药品信息化平台建设。这是阿里巴巴集团在医疗健康领域的一次重要布局。
(http://www.yywsb.com)

Comments are closed.